A Clinical Study Of NLY01 In Patient's With Early Parkinson's Disease

Overview

About this study

The purpose of this study is assess the safety, tolerability and effectiveness of NLY01 in subjects with early untreated Parkinson's disease (PD). Evidence suggests NLY01, a pegylated form of exenatide, may be beneficial in PD and is being developed as a potential treatment for neurodegenerative disorders.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patients who are diagnosed with Parkinson's disease according to UK Parkinson's Disease Society Brain Bank Clinical Diagnostic criteria or Movement Disorder Society Research Criteria.
  • Patients with Parkinson's disease according to protocol specified scale assessments.
  • DaTscan consistent with diagnosis of Parkinson's Disease.
  • Men or women.
  • Age 30 to 80 years old, inclusive.

Exclusion Criteria:

  • Diagnosis of secondary or atypical parkinsonism.
  • Prior use of dopaminergic treatment or MAO-B inhibitors for more than 28 days.
  • Medical or recreational use of marijuana or THC-containing compounds within 3 months of screening visit.
  • Pregnant or planning to become pregnant.
  • Metabolic, surgical, psychiatric or laboratory abnormality that would interfere with study compliance or safety in the judgment of the investigator.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Jacksonville, Fla.

Mayo Clinic principal investigator

Zbigniew Wszolek, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available
.
CLS-20488677

Mayo Clinic Footer